| 0.6 |
1.8 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 |
1.8 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 |
0.9 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
0.7 |
GO:0045349 |
regulation of dendritic cell cytokine production(GO:0002730) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 |
1.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
2.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.8 |
GO:1904749 |
rRNA export from nucleus(GO:0006407) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
0.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 |
0.5 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.2 |
0.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
1.6 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
0.4 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
1.0 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.4 |
GO:0032829 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) negative regulation of interleukin-2 biosynthetic process(GO:0045085) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
0.4 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.1 |
0.6 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.7 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
0.8 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
1.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.8 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.2 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.5 |
GO:0015701 |
bicarbonate transport(GO:0015701) response to arsenic-containing substance(GO:0046685) |
| 0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
1.5 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.0 |
0.1 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.0 |
0.2 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.6 |
GO:0060074 |
synapse maturation(GO:0060074) |